Gene rearrangements in the RET gene are detected in approximately 1% to 2% of patients with NSCLC and affect signaling pathways such as PI3K/AKT, JAK-STAT, and RAS/MAPK. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.